Web Results

www.alkermes.com/about-us/board-of-directors

The Alkermes Inc. Board of Directors provides significant leadership and guidance within the ... From May 2007 to September 2011, Mr. Cooke was Executive Vice President of Elan Corporation, plc (“Elan”) and Head of ... Wendy L. Dixon, Ph.D. ... Mr. Mitchell is a graduate of College of the Holy Cross (B.A. Economics) and ...

www.alkermes.com

Alkermes plc is a pharmaceutical manufacturing and biopharmaceutical company developing innovative medicines to help patients with serious chronic ...

investor.alkermes.com/mobile.view?c=92211&v=202&d=3&id=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTEyMDY1MTMzJkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3

Feb 16, 2018 ... ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ... Securities registered pursuant to Section 12(b) of the Act: ... in definitive proxy or information statements incorporated by reference in .... Alkermes plc is a fully integrated, global biopharmaceutical ...

investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1561074

May 9, 2011 ... Transaction Immediately Accretive to Cash Earnings; Alkermes plc to be ... WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) and Elan Corporation, plc ...

www.marketwatch.com/story/alkermes-execs-say-theyre-flummoxed-by-embarrassing-fda-drug-refusal-stock-plunges-2018-04-02

Apr 3, 2018 ... That was true for Alkermes PLC ALKS, +1.39% on Monday, when the drugmaker said it had received such a letter for its major depressive ...

seekingalpha.com/filing/3988653

Apr 26, 2018 ... QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE .... Alkermes plc (as used in this report, together with our subsidiaries, ... (b) references to the “biopharmaceutical industry” are intended to include ...... In January 2018, Janssen Pharmaceuticals NV and Janssen Pharmaceuticals, Inc.

markets.businessinsider.com/stocks/alkermes_1-stock

ALKS: Get the latest Alkermes stock price and detailed information including ALKS news, ... 44.55. Market Cap (USD). 6.39 B. Volume (Qty.) 17,962. Day Low. Day High .... Alkermes Plc IS a biopharmaceutical company, which engages in the development, ... Copyright © 2018 Insider Inc. and finanzen.net GmbH ( Imprint).

simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/breakeven-on-the-horizon-for-alkermes-plc-nasdaqalks

Apr 17, 2018 ... Alkermes plc's (NASDAQ:ALKS): Alkermes plc, a biopharmaceutical company, ... The US$6.59B market-cap company announced a latest loss of ... One thing I'd like to point out is that ALKS has managed its capital ... Should You Be Tempted To Buy Partner Jet Corp (CVE:PJT) Because Of Its PE Ratio?

www.sec.gov/Archives/edgar/data/1520262/000152026218000020/alks-20180323x8k.htm

Mar 29, 2018 ... PURSUANT TO SECTION 13 OR 15(d) OF THE ... On March 26, 2018, Alkermes plc (the “Company”), Alkermes, Inc., a subsidiary of the ...